Key facts
- In July 2025, 188 measles cases were reported by 13 countries in the EU/EEA. Seventeen countries reported zero cases.
- During the 12-month period, eight deaths attributable to measles were reported to ECDC by Romania (five), France (two) and Netherlands (one)
- Overall, case numbers decreased compared with the previous month; this is consistent with the seasonality of measles.
- No new outbreaks have been detected through supplementary epidemic intelligence activities either in the EU/EEA or other countries.
Overview
Since March 2025, an overall decrease in reported cases has been observed. A further decline in case numbers was expected over the summer months, in line with the known seasonality of measles.
In July 2025, 30 countries reported measles data, with 188 cases reported by 13 countries. There were 17 countries that reported zero cases.
Overall, case numbers decreased compared with the previous month, however this may be subject to change in the event of a future retrospective update. The highest case counts were reported by France (59), Romania (35), Belgium (26), Italy (25) and Netherlands (14).
Between 1 August 2024 to 31 July 2025, 30 EU/EEA Member States reported a total of 11 943 cases of measles, 8 545 (71.5%) of which were laboratory confirmed. of the 11 943 cases with known age, 4 938 (41.4%) were in children aged under five years; and 3 766 (31.5%) cases were aged 15 years or above. The highest notification rates were observed in infants under one year of age (399.8 cases per million) and children aged 1-4 years (209.6 cases per million).
Of 11 126 cases (93.2% of all cases) with a known age and vaccination status, 9 266 (83.3%) were unvaccinated, 1 015 (9.1%) were vaccinated with one dose of a measles-containing vaccine, 713 (6.4%) were vaccinated with two or more doses, and 113 (1.0%) were vaccinated with an unknown number of doses.
During the 12-month period, eight deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC by Romania (five), France (two) and Netherlands (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance has been conducted, with data collection between 8 and 9 September 2025. No large outbreaks have been detected, overall a decline in measles cases has been observed.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to EpiPulse Cases. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria has reported 144 measles cases in 2025 and as of 3 September, which is an increase of six cases since 30 July 2025. In the last four weeks, cases have been reported from Lower Austria, Tyrol, and Vorarlberg. Relevant information was available for 134 cases, 35 of which were hospitalised (26.1%), including one patient who was treated in an intensive care unit.
Belgium has reported 376 measles cases in January – July 2025, according to the ECDC’s Measles and rubella monthly report for July 2025. Outbreaks in Antwerp (n=138) and Limburg (n=37) have declined significantly, according to the Flemish public health authority (18 July 2025). In addition, the Flemish minister of health announced that second dose of measles-containing vaccine in Flanders will be given to 24-month old children instead of 7–8 year olds. The vaccination with an earlier schedule will commence on 13 October 2025. No other outbreaks have been reported in Belgium as of 8 September 2025.
Czechia reported 40 cases from January to 1 September 2025, an increase of 10 cases since 1 July 2025. No outbreaks have been reported in the country.
Denmark reported seven measles cases in 2025 as of 5 August 2025 (an increase of one since June 2025).
France has reported 802 cases as of 14 August 2025 (59 cases reported in July) with no new large outbreaks (classified as having ˃=5 cases). The previously
reported three larger outbreaks of 2025 in Nouvelle-Aquitaine (n=30), Occitanie (n=13) and Auvergne-Rhône-Alpes (n=13) are classified as not active (as of 14 August 2025) – in all three outbreaks the last case was reported in July this year. Overall, 70 departments reported at least one case. The five main departments affected are: Nord (16%), Bouches-du-Rhône (7%), I’Aude (6%), la Haute-Savoie (5%) and, l’Isère (5%). Two cases of measles were reported in overseas territories, both in Reunion.
At the national level, the number of reported cases appears to have peaked in March but remains at a high level. The increase is caused by transmission either due to imported cases or locally acquired infections.
Lithuania reported 8 cases in 2025 as of 5 September 2025, an increase of two cases since 8 July 2025.
The Netherlands reported 499 cases of measles as of 13 August 2025, an increase of 11 cases since 2 July 2025. The reports are mainly comprising of individual cases and several unrelated clusters. There is no indication of a national outbreak. In 2025, 55 cases were reported to have contracted measles abroad (two new cases reported in the past month), with most of these infections occurring in Morocco (35). Other cases had travel histories to Greece, Romania, Viet Nam, Türkiye, Belgium, Uganda, Iran, Bosnia and Herzegovina, China, Malaysia and France.
Poland has reported 71 measles cases in 2025 and as of 31 August, an increase of 11 cases since 31 July 2025.
Romania reported 8 320 measles cases and eight deaths in 2025 and as of 31 August, an increase of 160 cases since 31 July 2025. No new deaths were reported in this reporting period. A decreasing trend is observed in 2025, with fewer cases
reported per month compared to the same period in 2024.
Spain has reported 330 cases as of 31 August 2025 (increase by two
cases since 27 July 2025), of which 100 were imported and 86 were related to
imported cases.
Epidemiological summary for EU/EEA outermost territories with relevant epidemic intelligence updates:
Reunion reported a second case of measles on 8 August 2025 (regional report on 14 August 2025). The case is an unvaccinated adult with travel history to Thailand. According to health authorities the recent case is not epidemiologically linked to the autochthonous case reported on 17 July 2025.
Epidemiological summary for select countries outside of the EU/EEA with relevant epidemic intelligence updates:
England reported 742 laboratory confirmed measles cases, including one death, from January to 28 August 2025, an increase of 68 cases since the last report on 31July 2025. The situation with the outbreaks, affecting London (50% of the reported cases) and the Northwest regions has stabilised.
Ukraine reported 1 377 measles cases from January to July 2025, an increase of 181 cases in July only.
Moldova reported 172 cases of measles from 1 January to 27 June 2025. Nine of the cases were imported from Romania, Ukraine, Germany, Russia and Egypt. The age of the cases ranges from 3 months to 57 years.
According to the report by Africa CDC published on 6 September 2025, a total of 120 985 measles cases (9 274 confirmed) and 913 deaths (CFR: 0.75%) have been reported from 19 countries: Cameroon, Chad, Democratic Republic of Congo (DRC), Ethiopia, Guinea, Kenya, Malawi, Mali, Mauritania, Morocco (44 372 cases and 95 deaths), Mozambique, Nigeria, Rwanda, Senegal, Somalia, South Africa, Sudan, Uganda and Zambia.
According to the WHO Pan American Health Organization (WHO PAHO) report published on 23 August 2025, 10 867 confirmed cases were reported by ten countries, the majority of which have been reported by Canada (4 799), Mexico (4 267, including 14 deaths), and the United States (US) (1 407). Of the reported cases in PAHO region, 86% were either imported (n=1 797) or import-related cases (7 587).
As of 3 September 2025, the US has reported 1 431 confirmed measles cases in 2025, including three deaths in 42 jurisdictions. Ninety-two percent of the cases were unvaccinated or had an unknown vaccination status. Eighty-six percent of the cases were related to 35 outbreaks.
As of report on 8 August 2025, Mexico has reported 9 774 confirmed cases, including 14 deaths in weeks 1–30 of 2025.
According to a WHO Western Pacific Region (WHO WPRO) report for January to July 2025, there were 11 575 confirmed measles reported in the region in 14 countries. Most of the cases have been reported in Indonesia (3 276), Cambodia (2 969), China (1 429), and Mongolia (1 183).
For more information on the provisional number of cases outside the EU/EEA region, please visit the WHO website.
The numbers provided to WHO for EU/EEA countries are from EpiPulse Cases data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
ECDC assessment
Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.
Continued vigilance is essential due to suboptimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, the possible introduction from areas with ongoing transmission, and increased travel and population movement during the holiday period.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs that present measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.
ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with under-served populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
- In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up to date with recommended immunisations prior to departure.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.